The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 68 results:
Author Title Type [ Year(Asc)]
Filters: Author is Sarafidis, Pantelis  [Clear All Filters]
2020
Loutradis, C., & Sarafidis P. (2020).  Pharmacotherapy of hypertension in patients with pre-dialysis chronic kidney disease.. Expert Opin Pharmacother. 21(10), 1201-1217.
Schoina, M., Loutradis C., Theodorakopoulou M., Dimitroulas T., Triantafillidou E., Doumas M., et al. (2020).  The presence of diabetes mellitus further impairs structural and functional capillary density in patients with chronic kidney disease.. Microcirculation. e12665.
Sampani, E., Sarafidis P., Dimitriadis C., Kasimatis E., Daikidou D., Bantis K., et al. (2020).  Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review.. BMC Nephrol. 21(1), 276.
Sarafidis, P., Ferro C. J., Morales E., Ortiz A., Malyszko J., Hojs R., et al. (2020).  SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.. Nephrol Dial Transplant. 35(10), 1825.
Piperidou, A., Loutradis C., & Sarafidis P. (2020).  SGLT-2 inhibitors and nephroprotection: current evidence and future perspectives.. J Hum Hypertens.
Fernandez-Fernandez, B., Sarafidis P., Kanbay M., Navarro-González J. F., Soler M. José, Gorriz J. Luis, et al. (2020).  SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia.. Clin Kidney J. 13(5), 728-733.
Sarafidis, P., Loutradis C., Ferro C. J., & Ortiz A. (2020).  SGLT-2 Inhibitors to Treat Hyponatremia Associated with SIADH: A Novel Indication?. Am J Nephrol. 51(7), 553-555.
Lampropoulou, I. Theologia, Stangou Μ., Sarafidis P., Gouliovaki A., Giamalis P., Tsouchnikas I., et al. (2020).  TNF-α pathway and T-cell immunity are activated early during the development of diabetic nephropathy in Type II Diabetes Mellitus.. Clin Immunol. 215, 108423.
Mallamaci, F., Torino C., Sarafidis P., Ekart R., Loutradis C., Siamopoulos K., et al. (2020).  Treatment-resistant hypertension in the hemodialysis population: a 44-h ambulatory blood pressure monitoring-based study.. J Hypertens. 38(9), 1849-1856.
2019
Korogiannou, M., Xagas E., Marinaki S., Sarafidis P., & Boletis J. N. (2019).  Arterial Stiffness in Patients With Renal Transplantation; Associations With Co-morbid Conditions, Evolution, and Prognostic Importance for Cardiovascular and Renal Outcomes.. Front Cardiovasc Med. 6, 67.
Ferro, C. J., Mark P. B., Kanbay M., Sarafidis P., Heine G. H., Rossignol P., et al. (2019).  Author Correction: Lipid management in patients with chronic kidney disease.. Nat Rev Nephrol. 15(2), 121.
Demosthenous, C., Vlachaki E., Apostolou C., Eleftheriou P., Kotsiafti A., Vetsiou E., et al. (2019).  Beta-thalassemia: renal complications and mechanisms: a narrative review.. Hematology. 24(1), 426-438.
Pappaccogli, M., Labriola L., Van der Niepen P., Pruijm M., Vogt L., Halimi J-M., et al. (2019).  Is blood pressure measured correctly in dialysis centres? Physicians' and patients' views.. Nephrol Dial Transplant. 34(9), 1612-1615.
Piperidou, A., Sarafidis P., Boutou A., Thomopoulos C., Loutradis C., Alexandrou M. Eleni, et al. (2019).  The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.. J Hypertens. 37(7), 1334-1343.
Piperidou, A., Sarafidis P., Boutou A., Thomopoulos C., Loutradis C., Alexandrou M. Eleni, et al. (2019).  The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus. Journal of Hypertension. 1.
Loutradis, C., Papadopoulou E., Theodorakopoulou M., Karagiannis A., & Sarafidis P. (2019).  The effect of SGLT-2 inhibitors on blood pressure: a pleiotropic action favoring cardio- and nephroprotection. Future Medicinal Chemistry. 2019 Jun;11(11):1285-1303.
Loutradis, C., Papadopoulou E., Theodorakopoulou M., Karagiannis A., & Sarafidis P. (2019).  The effect of SGLT-2 inhibitors on blood pressure: a pleiotropic action favoring cardio- and nephroprotection.. Future Med Chem. 11(11), 1285-1303.
Alexandrou, M-E., Papagianni A., Tsapas A., Loutradis C., Boutou A., Piperidou A., et al. (2019).  Effects of mineralocorticoid receptor antagonists in proteinuric kidney disease: a systematic review and meta-analysis of randomized controlled trials.. J Hypertens. 37(12), 2307-2324.
Theodorakopoulou, M., Raptis V., Loutradis C., & Sarafidis P. (2019).  Hypoxia and Endothelial Dysfunction in Autosomal-Dominant Polycystic Kidney Disease.. Semin Nephrol. 39(6), 599-612.
Loutradis, C., Bikos A., Raptis V., Afkou Z., Tzanis G., Pyrgidis N., et al. (2019).  Nebivolol reduces short-term blood pressure variability more potently than irbesartan in patients with intradialytic hypertension.. Hypertens Res. 42(7), 1001-1010.
Sarafidis, P., Ferro C. J., Morales E., Ortiz A., Malyszko J., Hojs R., et al. (2019).  SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.. Nephrol Dial Transplant. 34(2), 208-230.
Sarafidis, P., & Papagianni A. (2019).  Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections.. Ann Intern Med. 171(12), 943-944.
Memmos, E., Sarafidis P., Pateinakis P., Tsiantoulas A., Faitatzidou D., Giamalis P., et al. (2019).  Soluble Klotho is associated with mortality and cardiovascular events in hemodialysis.. BMC Nephrol. 20(1), 217.
2018
Bikos, A., Angeloudi E., Memmos E., Loutradis C., Karpetas A., Ginikopoulou E., et al. (2018).  A Comparative Study of Short-Term Blood Pressure Variability in Hemodialysis Patients with and without Intradialytic Hypertension.. Am J Nephrol. 48(4), 295-305.
Ferro, C. J., Mark P. B., Kanbay M., Sarafidis P., Heine G. H., Rossignol P., et al. (2018).  Lipid management in patients with chronic kidney disease.. Nat Rev Nephrol. 14(12), 727-749.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.